Prescribing Information
This site is intended for US Healthcare Professionals only
The page you were trying to access is not available. You may have accessed this page via an outdated link, or typed in the URL incorrectly. You may find what you're looking for by searching this site or using the navigation.
Axumin® (fluciclovine F 18) injection is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following prior treatment.
To report suspected adverse reactions to Axumin, call 1-855-AXUMIN1 (1-855-298-6461) or contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see Axumin full Prescribing Information.
You are now leaving Axumin.com. Do you wish to proceed?